IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,196,190 | +1198.1% | 1,361,800 | +1908.6% | 0.10% | +955.6% |
| Q2 2023 | $477,312 | +15.2% | 67,800 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $414,258 | -54.7% | 67,800 | -28.9% | 0.01% | -30.8% |
| Q3 2022 | $914,000 | -79.8% | 95,397 | -76.7% | 0.01% | -79.4% |
| Q2 2022 | $4,521,000 | +442.7% | 409,500 | +719.0% | 0.06% | +530.0% |
| Q1 2022 | $833,000 | -95.8% | 50,000 | -95.2% | 0.01% | -95.5% |
| Q4 2021 | $20,022,000 | +352.3% | 1,048,825 | +484.3% | 0.22% | +348.0% |
| Q3 2021 | $4,427,000 | +254.7% | 179,507 | +274.0% | 0.05% | +212.5% |
| Q2 2021 | $1,248,000 | -82.8% | 48,000 | -79.1% | 0.02% | -89.7% |
| Q1 2021 | $7,256,000 | -37.2% | 229,200 | -8.0% | 0.16% | -40.7% |
| Q4 2020 | $11,554,000 | +602.4% | 249,000 | +398.0% | 0.26% | +592.1% |
| Q3 2020 | $1,645,000 | -78.6% | 50,000 | -82.2% | 0.04% | -85.2% |
| Q2 2020 | $7,702,000 | +77.2% | 280,600 | +93.3% | 0.26% | +4.5% |
| Q1 2020 | $4,347,000 | -0.5% | 145,200 | -8.0% | 0.25% | +68.5% |
| Q4 2019 | $4,371,000 | -39.0% | 157,900 | -59.9% | 0.15% | -60.9% |
| Q3 2019 | $7,171,000 | +95.6% | 394,000 | +163.4% | 0.37% | +101.6% |
| Q2 2019 | $3,667,000 | – | 149,600 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |